Table 2.
Variable | ALC group (n = 34) | Placebo group (n = 35) | p value |
---|---|---|---|
Admission NIHSS score, mean ± SD | 13.06 ± 3.70 | 12.26 ± 5.03 | 0.45 |
| |||
3-month after-stroke NIHSS score, mean ± SD | 7.24 ± 4.39 | 9.60 ± 4.32 | 0.02 |
| |||
NIHSS alteration from admission to 3 months after stroke, mean ± SD | −5.82 ± 4.51 | −2.83 ± 3.08 | 0.002 |
| |||
Admission mRS score, mean ± SD | 2.53 ± 0.78 | 2.51 ± 0.98 | 0.62 |
| |||
3-month after-stroke mRS score, mean ± SD | 1.65 ± 1.6 | 2.54 ± 1.60 | 0.02 |
| |||
mRS alteration from baseline to 3 months after stroke, mean ± SD | −0.94 ± 1.30 | 0.11 ± 1.34 | 0.002 |
Note: ALC = acetyl-L-carnitine; NIHSS = National Institutes of Health Stroke Scale; mRS = modified Rankin Scale. The significant p value is shown in bold type.